Table 3.
Treatment emergent adverse events occurring in ≥ 10% of patients (n =17)
| Adverse Event | Grade; n (%) | |||
|---|---|---|---|---|
| All grades | 1-2 | 3 | 4 | |
| Fatigue | 9 (53) | 8 (47) | 1 (6) | 0 |
| Nausea | 7 (41) | 7 (41) | 0 | 0 |
| Abdominal pain or bloating | 4 (24) | 4 (24) | 0 | 0 |
| Vaginal discharge | 4 (24) | 4 (24) | 0 | 0 |
| Dizziness | 3 (18) | 3 (18) | 0 | 0 |
| Pain, breast | 3 (18) | 3 (18) | 0 | 0 |
| Anorexia | 3 (18) | 3 (18) | 0 | 0 |
| Dyspnea | 2 (12) | 0 | 2 (12) | 0 |
| Edema | 2 (12) | 2 (12) | 0 | 0 |
| Constipation | 2 (12) | 2(12) | 0 | 0 |
| Pain, musculoskeletal | 2 (12) | 2 (12) | 0 | 0 |
| Weight gain | 2 (12) | 2 (12) | 0 | 0 |
| Vomiting | 2 (12) | 1 (6) | 1 (6) | 0 |
| Headache | 2 (12) | 2 (12) | 0 | 0 |
| Hypoalbuminemia | 7 (41) | 7 (41) | 0 | 0 |
| Hypocalcemia | 2 (12) | 2 (12) | 0 | 0 |